BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 29093096)

  • 1. MicroRNA-Based Attenuation of Influenza Virus across Susceptible Hosts.
    Waring BM; Sjaastad LE; Fiege JK; Fay EJ; Reyes I; Moriarity B; Langlois RA
    J Virol; 2018 Jan; 92(2):. PubMed ID: 29093096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a safe and effective live viral vaccine by virus self-attenuation using species-specific artificial microRNA.
    Li J; Arévalo MT; Diaz-Arévalo D; Chen Y; Choi JG; Zeng M
    J Control Release; 2015 Jun; 207():70-6. PubMed ID: 25858415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
    Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
    Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of Live Attenuated Influenza Virus by Using Codon Usage Bias.
    Fan RL; Valkenburg SA; Wong CK; Li OT; Nicholls JM; Rabadan R; Peiris JS; Poon LL
    J Virol; 2015 Nov; 89(21):10762-73. PubMed ID: 26269186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of the influenza virus by microRNA response element in vivo and protective efficacy against 2009 pandemic H1N1 virus in mice.
    Feng C; Tan M; Sun W; Shi Y; Xing Z
    Int J Infect Dis; 2015 Sep; 38():146-52. PubMed ID: 26163223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rearrangement of Influenza Virus Spliced Segments for the Development of Live-Attenuated Vaccines.
    Nogales A; DeDiego ML; Topham DJ; Martínez-Sobrido L
    J Virol; 2016 Jul; 90(14):6291-6302. PubMed ID: 27122587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-mediated species-specific attenuation of influenza A virus.
    Perez JT; Pham AM; Lorini MH; Chua MA; Steel J; tenOever BR
    Nat Biotechnol; 2009 Jun; 27(6):572-6. PubMed ID: 19483680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.
    Nogales A; Steel J; Liu WC; Lowen AC; Rodriguez L; Chiem K; Cox A; García-Sastre A; Albrecht RA; Dewhurst S; Martínez-Sobrido L
    Microbiol Spectr; 2022 Jun; 10(3):e0007822. PubMed ID: 35583364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
    Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
    J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Approaches for The Development of Live Attenuated Influenza Vaccines.
    Blanco-Lobo P; Nogales A; Rodríguez L; Martínez-Sobrido L
    Viruses; 2019 Feb; 11(2):. PubMed ID: 30813325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.
    Richt JA; Lekcharoensuk P; Lager KM; Vincent AL; Loiacono CM; Janke BH; Wu WH; Yoon KJ; Webby RJ; Solórzano A; García-Sastre A
    J Virol; 2006 Nov; 80(22):11009-18. PubMed ID: 16943300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing the yield of seasonal influenza viruses through manipulation of microRNAs in Madin-Darby canine kidney cells.
    Saengchoowong S; Nimsamer P; Khongnomnan K; Poomipak W; Praianantathavorn K; Rattanaburi S; Poovorawan Y; Zhang Q; Payungporn S
    Exp Biol Med (Maywood); 2022 Aug; 247(15):1335-1349. PubMed ID: 35666095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an Alternative Modified Live Influenza B Virus Vaccine.
    Santos JJS; Finch C; Sutton T; Obadan A; Aguirre I; Wan Z; Lopez D; Geiger G; Gonzalez-Reiche AS; Ferreri L; Perez DR
    J Virol; 2017 Jun; 91(12):. PubMed ID: 28381580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A viable recombinant rhabdovirus lacking its glycoprotein gene and expressing influenza virus hemagglutinin and neuraminidase is a potent influenza vaccine.
    Ryder AB; Buonocore L; Vogel L; Nachbagauer R; Krammer F; Rose JK
    J Virol; 2015 Mar; 89(5):2820-30. PubMed ID: 25540378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.
    Rodriguez L; Blanco-Lobo P; Reilly EC; Maehigashi T; Nogales A; Smith A; Topham DJ; Dewhurst S; Kim B; Martínez-Sobrido L
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31658679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.
    Parks CL; Latham T; Cahill A; O'neill RE; Passarotti CJ; Buonagurio DA; Bechert TM; D'Arco GA; Neumann G; Destefano J; Arendt HE; Obregon J; Shutyak L; Hamm S; Sidhu MS; Zamb TJ; Udem SA
    Virology; 2007 Oct; 367(2):275-87. PubMed ID: 17599381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells.
    Yan LM; Lau SPN; Poh CM; Chan VSF; Chan MCW; Peiris M; Poon LLM
    mBio; 2020 Mar; 11(2):. PubMed ID: 32127444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of live-attenuated influenza virus.
    He W; Wang W; Han H; Wang L; Zhang G; Gao B
    PLoS One; 2013; 8(3):e60413. PubMed ID: 23555969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.